Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
MRSA is here to stay
but it can be
controlled
| The first 150 words of the full text of this article appear below. |
S taphylococcus aureus is well adapted to the human body, capable of spreading from person to person, hiding in intracellular compartments,1 and, most importantly, inducing various forms of human disease. During infection the bacterial cells produce a large variety of virulence factors, among which, for instance, are molecules that subtly interfere with the chemotaxis of neutrophils to the site of infection.2 Adding to the complexity of the infectious process is the fact that the host also responds in a variety of ways immunologically, sometimes producing a certain degree of resistance to infection.3 S aureus has remained among the top three clinically important pathogens over the past few decades, and a particular worry has been the rise of methicillin resistant strains.
The clinical need for an effective vaccine against S aureus
is clear, but since infections caused by S aureus are
complex and as yet largely undefined (from the perspective of
Read all Rapid Responses